Telomir Pharmaceuticals (TELO) Share-based Compensation (2024 - 2026)
Telomir Pharmaceuticals (TELO) posted Share-based Compensation of $11.0 million for Q4 2025, up 8330.77% sequentially from $130000.0 in Q3 2025, and up 1461.08% YoY from $702075.8 in Q4 2024.
Telomir Pharmaceuticals (TELO) Share-based Compensation (2024 - 2026) Analysis & Trends
Telomir Pharmaceuticals has reported Share-based Compensation for 2 years, with the latest figure at $11.0 million in Q4 2025.
- Quarterly Share-based Compensation rose 1461.08% year-over-year to $11.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $15.4 million (changed N/A YoY) and the FY2025 annual result came in at $11.8 million, up 195.0% from the prior year.
- Share-based Compensation improved to $11.0 million in Q4 2025 per TELO's latest filing, from $130000.0 in the prior quarter.
- Over five years, Share-based Compensation peaked at $11.0 million in Q4 2025 and troughed at -$805240.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 86.63 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 41.25 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 28.05 Mn |
| 10 | Telomir Pharmaceuticals | 68.14 Mn | 68.14 Mn | - | 587,737.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 587,737.00 |
| Jun 30, 2026 | 587,737.00 |
| Dec 31, 2025 | 10.96 Mn |
| Dec 31, 2025 | 10.96 Mn |
| Sep 30, 2025 | 130,000.00 |
| Sep 30, 2025 | 130,000.00 |
| Jun 30, 2025 | 3.82 Mn |
| Jun 30, 2025 | 3.82 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | -805,240.00 |
| Dec 31, 2024 | -805,240.00 |
| Sep 30, 2024 | 4.30 Mn |
| Sep 30, 2024 | 4.30 Mn |